1. Integrating Regulatory Affairs, Safety, And Clinical R&D To Manage Data And Drive Value Across the Enterprise

    Regulatory Affairs, Safety, and Clinical R&D are traditionally managed as three separate departments, each with their own business processes and software systems. As the number of these touch points increase, it motivates the desire and urgency for better integration in order to operate more nimbly, reduce data discrepancies, and lower costs.

  2. Ensuring Safety And Multivigilance Compliance Across The Product Lifecycle

    The regulatory landscape for safety has changed dramatically over the last four years and shows no signs of slowing down any time soon. This Webcast provides an update of the current situation worldwide, a preview of what the next few years will bring, and a solution using Oracle Safety Cloud to remain compliant through it all. Hot topics such as Brexit, combination products, E2B(R3), EVDAS/eRMR, medical device regulations, and IDMP are also included.

  3. Increase Your Safety Insight With And Signal Management Analytics

    Safety decisions should be driven by data; the right aggregations combined with the right analytical tools can make all the difference for your benefit-risk assessments and compliance metrics. Watch this webcast to learn how Oracle Safety Cloud provides you with a unified, flexible, and powerful solution

  4. Why Life Science Companies Are Moving To The Oracle Safety Cloud

    Please join Oracle Health Sciences’ Senior Safety Strategist Marianne Savage and Consulting Sales Manager Mark Lee to learn why life science organizations are moving their safety applications into the cloud, and the benefits gained when compared to maintaining an on-premise environment.

  5. How Artificial Intelligence Will Revolutionize Safety

    Watch this webcast to learn how artificial intelligence, natural language processing, and machine learning are poised to change the way we do pharmacovigilance.

  6. Standardization Drives Transparency And Optimization Of Contract/Budget Processes In Clinical Trial Startup

    For years, this laborious step has ranked as the lengthiest of study startup activities, and recent data suggest it remains the primary cause of site activation failure. This webcast will cover How granular metrics empower business intelligence, process optimization and efficient resource allocation and other steps to help avoid bottlenecks and delays.

  7. Refocusing On Risk Mitigation In Starting Clinical Trials

    While risk management efforts in drug development have focused mostly on post-marketing drug safety, the clinical trials process has its own mix of potential risks waiting to derail a company's multimillion-dollar development programs. For study startup, a problematic area of clinical trials, these risks include site selection and patient enrollment issues, budget and contracting delays, logistical problems with timely drug shipments, and regulatory hurdles.